News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Music

Gene Simmons’ son following in dad’s rock footsteps

simmons

Nick Simmons, 25, is starting his own rock band.

in Music

Chrissie Hynde calls today’s singers ‘porn stars’

hynde

The rocker says there's a difference between talent and "porn stars trying to make records."

in Music

James Brown’s kids allege abuse, murder

jamesbrown

Grisly new books detail Brown's reputation as an abusive husband and suggest the singer was murdered.